+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Meloxicam Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Meloxicam Tablet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Axial Spondyloarthritis (AXSPA) Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Axial Spondyloarthritis (AXSPA) Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • March 2025
  • 103 Pages
  • Global
From
Alopecia Areata: Opportunity Assessment and Forecast to 2033 - Product Thumbnail Image

Alopecia Areata: Opportunity Assessment and Forecast to 2033

  • Report
  • March 2025
  • 81 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
N-Formyl Peptide Receptor 2 - Pipeline Review, H2 2019 - Product Thumbnail Image

N-Formyl Peptide Receptor 2 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 32 Pages
  • Global
From
Non-steroidal Anti-inflammatory Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non-steroidal Anti-inflammatory Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 101 Pages
  • Global
From
Celiac Disease Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Celiac Disease Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 82 Pages
  • Global
From
Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Gout Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 93 Pages
  • Global
From
Aspirin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Aspirin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2025
  • 98 Pages
  • Global
From
Aspirin API Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Aspirin API Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • January 2025
  • 85 Pages
  • Global
From
Arginine Ibuprofen Granule Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Arginine Ibuprofen Granule Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
KSA Gout Therapeutics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Thumbnail Image

KSA Gout Therapeutics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • October 2025
  • 80 Pages
  • Saudi Arabia
From
Uveitis: Opportunity Assessment and Forecast - Product Thumbnail Image

Uveitis: Opportunity Assessment and Forecast

  • Report
  • March 2025
  • 74 Pages
  • Global
From
Autoimmune Drugs Markets in China - Product Thumbnail Image

Autoimmune Drugs Markets in China

  • Report
  • March 2025
  • 201 Pages
  • China
From
Arthritis Treatment Drugs Markets in China - Product Thumbnail Image

Arthritis Treatment Drugs Markets in China

  • Report
  • August 2024
  • 238 Pages
  • China
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2027 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2027

  • Report
  • July 2023
  • 200 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more